PEPVERAAUTHENTIC HIGH-QUALITY PEPTIDES
SIGN IN
5-Amino-1MQ (Oral)
NICHE · I

5-Amino-1MQ (Oral)

Same compound, oral form.

From / per milligram
$400$—/mg · 50MG
Sizes available
—
Lab certificate (COA)
Arrives with shipment
View test certificate →

· Research-grade only · Not for human consumption · 21+ ·

What is it

Oral 5-Amino-1MQ. NNMT inhibitor (metabolic and body-fat research) in capsule form.

Mechanism · Oral-stable NNMT inhibitor. Pre-clinical / early human stage.

Who

Best for. Not for.

Best for

  • Oral-bioavailable NNMT inhibitor users who want
  • Pre-clinical fat-loss / lean-mass research framing
  • Metabolic experimentation while avoiding injection

Not for

  • Users requiring human clinical evidence (still animal and early-human stage)
  • Pregnancy / planned pregnancy
  • Long-term continuous use (long-term safety not established)
  • FDA / EMA approval not established. Research-only
What it does

Mechanism, dose, ramp, risk.

Mechanism
NNMT inhibitor in oral capsule.Source · PEPVERA editorial
Target dose
150 mg / day, oral.Source · PEPVERA editorial
Ramp
8-Week cycle.Source · PEPVERA editorial
Risks
Limited human data.Source · PEPVERA editorial
Alternatives

Compared to its siblings.

★ Currently viewing

5-Amino-1MQ (Oral)

Oral 5-Amino-1MQ. NNMT inhibitor (metabolic and body-fat research) in capsule form.

Pros

  • · Oral capsule avoids injection burden of tirzepatide.
  • · NNMT-specific mechanism distinct from SLU-PP-332's ERRα pathway.

Cons

  • · Pre-clinical only; tirzepatide has FDA Mounjaro 2022 and large evidence base.
  • · Limited human data versus tirzepatide's clinical dataset.

SLU-PP-332

ERRα agonist exercise-mimetic. Different mechanism.

Pros

  • · Pre-clinical fat loss

Cons

  • · Small molecule, not NNMT

See SLU-PP-332 →

Tirzepatide

FDA-approved GLP-1 / GIP. The largest clinical dataset.

Pros

  • · FDA Mounjaro 2022
  • · Large evidence base

Cons

  • · Injection burden

See Tirzepatide →

How we verify

COA per supplier

Published, in-house, or shipment-time

Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.

→ How we verify suppliers→ Refund policy
Fat lossMetabolic
Suppliers

Compare 0 suppliers

No verified suppliers yet for this compound.

❄ COLD-CHAIN · 5–9 DAYS

Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.

Dosing protocol

Week 1–2

150 mg / day, oral.

Initiation

Week 3–4

150 mg / day, oral.

Signal emerges

Week 5–8

150 mg / day, oral.

Hold

Week 9–12

Cycle review

Assess

Reconstitution

Draw 20 units.

5 mg = 0.20 mL at 25.00 mg/mL. 10.0 doses per vial.

niche · I

5-Amino-1MQ (Oral) · 50mg